- Filed
- Mar 4, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 6.53M sh |
| Capex | FY 2024 · Dec 31, 2024 | $0 |
| Capex | FY 2024 · Dec 31, 2023 | $20.66M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 6.5M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$82.03M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $9.2M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $10.56M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $99.8M |
| Current Assets | FY 2024 · Dec 31, 2023 | $160.76M |
| Total Assets | FY 2024 · Dec 31, 2023 | $325.63M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$24.00 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$24.00 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $47.55M |
| Net Income | FY 2024 · Dec 31, 2023 | −$156.09M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$159.17M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $363.61M |